Discover
WHWK
Whitehawk Therapeutics, Inc.
4.20
2 x 2.98
2 x 5.27
bid
ask
+
0.12
2.94%
2 @ 07:30 PM
4.20 +0.00 (0.00%)
| Ytd | 73.55% | |
| 1y | 113.20% |
4.09
day range
4.26
1.89
52 week range
5.10
| Open | 4.09 | Prev Close | 4.08 | Low | 4.09 | High | 4.26 | Mkt Cap | 239.44M |
| Vol | 1.97M | Avg Vol | 458.68K | EPS | -1.21 | P/E | N/A | Forward P/E | N/A |
| Beta | 0.81 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 4.28 | 200-d Avg | 3.69 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 18.11M | ||
| Research and Development Expense | 12.89M | ||
| Selling, General and Administrative Expense | 5.22M | ||
| Operating Income | -18.11M | ||
| Net Income | -16.64M | ||
| Net Income Common Stock | -16.64M | ||
| Net Income Common Stock (USD) | -16.64M | ||
| Consolidated Income | -16.64M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -16.64M | ||
| Earning Before Interest & Taxes (USD) | -16.64M | ||
| Weighted Average Shares | 82.89M | ||
| Weighted Average Shares Diluted | 82.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 85.23M | ||
| Cash and Equivalents (USD) | 85.23M | ||
| Investments | 104.75M | ||
| Investments Current | 104.75M | ||
| Current Assets | 192.41M | ||
| Property, Plant & Equipment Net | 1000 | ||
| Total Assets | 193.99M | ||
| Current Liabilities | 11.07M | ||
| Total Liabilities | 11.07M | ||
| Accumulated Retained Earnings (Deficit) | -392.08M | ||
| Accumulated Other Comprehensive Income | -63.00K | ||
| Shareholders Equity | 182.93M | ||
| Shareholders Equity (USD) | 182.93M | ||
| Assets Non-Current | 1.58M | ||
| Trade and Non-Trade Payables | 1.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow from Financing | 81.84M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.44M | ||
| Issuance (Purchase) of Equity Shares | 81.93M | ||
| Net Cash Flow from Investing | -16.87M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -16.87M | ||
| Net Cash Flow from Operations | -14.53M | ||
| Share Based Compensation | 1.52M | ||